Amphion Innovations plc

Directors' Dealings
Directors Receive Shares in Lieu of Fees

London and New York, 13 November 2013- Amphion Innovations plc (the “Company”) (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 663,821 ordinary shares, representing 0.45% of the enlarged issued share capital, to certain of its Board members as their directors’ fees for the fourth quarter of 2012 and the first three quarters of 2013, priced at 4.175 pence, being the average of the closing mid-market price for the five days leading up to the market close on 12 November 2013. Following this issue, the directors’ shareholdings in the Company are as follows:

Director Number of
New Shares
Percentage of
voting rights
R. James Macaleer 501,321 24,480,266 16.666%
Gerard Moufflet 162,500 862,500 0.587%

Director, Anthony Henfrey waived his fees for the fourth quarter of 2012 as well as for the first three quarters of 2013.

Admission of the 663,821 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 19 November 2013.  Following this allotment the total issued share capital of the Company will increase to 146,884,071 ordinary shares with each share holding one voting right.

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008

Panmure Gordon Limited
Freddy Crossley / Grishma Patel (Corporate Finance)
Adam Pollock (Corporate Broking)
+44 020 7886 2500

About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: